Huge growth in revenues and at 80%+ gross margins. Removing BigT consolidation piece, SRAX is now EBITDA positive on sequire product.
Miglino instituted $10M buy-back program and special $6.5M dividend as confidence in market's undervaluing of SRAX. Said will be paid by new SRAX sales and BigT monetization. Given size of SRAX today, these are actually quite big numbers relative to their balance sheet. Sense a ton of confidence here, including in BigT monetization. In fact, Miglino called out this value disconnect - trading only 3x/sales on latest guidance of $30-32M -- on the call.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.